VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations

Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies

(2013) Miroslav Dostalek et al.   CLINICAL PHARMACOKINETICS

Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer

(2013) Laure Belmont et al.   INTERNATIONAL JOURNAL OF CANCER

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

(2013) Alice T. Shaw et al.   NEW ENGLAND JOURNAL OF MEDICINE

CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis

(2012) T. Jiang et al.   BLOOD

Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer

(2012) Lidia Moserle et al.   EMBO Molecular Medicine

Anti-angiogenic drug discovery: lessons from the past and thoughts for the future

(2012) Jessie M Wu et al.   Expert Opinion on Drug Discovery

Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

(2012) Nathan T. Ihle et al.   JNCI-Journal of the National Cancer Institute

Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib in a French Prospective Cohort (ERMETIC Project—Part 2)

(2012) Jacques Cadranel et al.   Journal of Thoracic Oncology

Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy

(2011) Satoru Takahashi   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads

(2011) Annamaria Rapisarda et al.   CELL CYCLE

Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells

(2011) L. von Baumgarten et al.   CLINICAL CANCER RESEARCH

Antiangiogenic therapy, hypoxia and metastasis: risky liaisons, or not?

(2011) Katrien De Bock et al.   Nature Reviews Clinical Oncology

The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors

(2011) Agnès Maillet et al.   PHARMACEUTICAL RESEARCH

A Differential Concentration-Dependent Effect of IVIg on Neutrophil Functions: Relevance for Anti-Microbial and Anti-Inflammatory Mechanisms

(2011) Sarah Casulli et al.   PLoS One

Suppression of hypoxia-induced HIF-1α accumulation by VEGFR inhibitors: Different profiles of AAL993 versus SU5416 and KRN633

(2010) Hyun Seung Ban et al.   CANCER LETTERS

HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer

(2010) Autumn L Jackson et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: Relation to prognosis

(2009) Barbara Bonnesen et al.   LUNG CANCER

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1

(2008) N. Korsisaari et al.   CLINICAL CANCER RESEARCH

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE